They want options that are easy to test, easy to track, and aligned with bigger goals like better training output, faster recovery, steadier mood, and more sustainable day-to-day performance
Ten patients with obesity and type 2 diabetes received weekly subcutaneous semaglutide, escalated from 0.25 mg to 1 mg over 4 weeks and maintained for 8 more weeks (12 weeks total)
Research Objective 1.2
Explore patient assistance programs offered by pharmaceutical companies like Novo Nordisk and Eli Lilly, which may help reduce out-of-pocket costs for the brand-name medications
Other etiologies of liver disease, including alcohol-induced or drug-induced liver disease, viral or auto-immune hepatitis, metabolic and cholestatic liver diseases, were excluded using specific clinical, biochemical, histological and/or radiographic criteria
The conversation around these medications has evolved rapidly, from being prescribed solely for type 2 diabetes, to expanded use for the treatment of obesity, cardiovascular, kidney, and liver disease, as well as arthritis, sleep apnea and even for the treatment of substance abuse disorder
